NLS Pharmaceutics (NLS Pharmaceutics) Accumulated other comprehensive income (loss) : $-0.16 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. NLS Pharmaceutics's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $-0.16 Mil.

NLS Pharmaceutics's quarterly Accumulated other comprehensive income (loss) declined from Dec. 2022 ($-0.05 Mil) to Jun. 2023 ($-0.07 Mil) and declined from Jun. 2023 ($-0.07 Mil) to Dec. 2023 ($-0.16 Mil).

NLS Pharmaceutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 ($-0.15 Mil) to Dec. 2022 ($-0.05 Mil) but then declined from Dec. 2022 ($-0.05 Mil) to Dec. 2023 ($-0.16 Mil).

NLS Pharmaceutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for NLS Pharmaceutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NLS Pharmaceutics Accumulated other comprehensive income (loss) Chart

NLS Pharmaceutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-0.02

-0.15

-0.05

-0.16

NLS Pharmaceutics Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial								-0.15	-0.03	-0.05	-0.07	-0.16

NLS Pharmaceutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

NLS Pharmaceutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of NLS Pharmaceutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

NLS Pharmaceutics (NLS Pharmaceutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

The Circle 6, Zurich, CHE, 8058

Website

https://www.nlspharma.com

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.